Related Resources

Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform
Press Release | KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board
Contact Us

Are you looking to accelerate your program or just want to learn more about our services?

Connect with our team and we will get back to you quickly.

View Capabilities

Connect with our team and we will get back to you quickly.

View Capabilities
JSR_Logo_footer-01

Copyright © 2019 KBI Biopharma. All Rights Reserved. | Privacy Policy